Kintegral Advisory’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.54M | Hold |
11,984
| – | – | 0.21% | 112 |
|
|
2026
Q1 | $2.35M | Sell |
11,984
-531
| -4% | -$103K | 0.22% | 109 |
|
|
2025
Q4 | $2.17M | Sell |
12,515
-343
| -3% | -$62.5K | 0.18% | 119 |
|
|
2025
Q3 | $2.45M | Sell |
12,858
-57
| -0.4% | -$10.1K | 0.21% | 114 |
|
|
2025
Q2 | $2.32M | Sell |
12,915
-20
| -0.2% | -$3.47K | 0.21% | 115 |
|
|
2025
Q1 | $2.19M | Sell |
12,935
-43
| -0.3% | -$7.06K | 0.22% | 115 |
|
|
2024
Q4 | $1.96M | Sell |
12,978
-605
| -4% | -$94.1K | 0.18% | 126 |
|
|
2024
Q3 | $2.11M | Sell |
13,583
-178
| -1% | -$26.6K | 0.19% | 127 |
|
|
2024
Q2 | $1.88M | Buy |
13,761
+2,374
| +21% | +$325K | 0.18% | 127 |
|
|
2024
Q1 | $1.52M | Sell |
11,387
-35
| -0.3% | -$4.54K | 0.15% | 132 |
|
|
2023
Q4 | $1.57M | Sell |
11,422
-72
| -0.6% | -$9.47K | 0.17% | 128 |
|
|
2023
Q3 | $1.4M | Sell |
11,494
-7
| -0.1% | -$933 | 0.17% | 128 |
|
|
2023
Q2 | $1.62M | Hold |
11,501
| – | – | 0.19% | 118 |
|
|
2023
Q1 | $1.63M | Sell |
11,501
-618
| -5% | -$88.4K | 0.21% | 118 |
|
|
2022
Q4 | $1.9M | Sell |
12,119
-623
| -5% | -$89.5K | 0.25% | 116 |
|
|
2022
Q3 | $1.56M | Hold |
12,742
| – | – | 0.22% | 114 |
|
|
2022
Q2 | $1.69M | Buy |
12,742
+270
| +2% | +$36.8K | 0.22% | 109 |
|
|
2022
Q1 | $1.71M | Buy |
12,472
+279
| +2% | +$38.9K | 0.19% | 116 |
|
|
2021
Q4 | $2.11M | Hold |
12,193
| – | – | 0.22% | 110 |
|
|
2021
Q3 | $1.77M | Hold |
12,193
| – | – | 0.21% | 116 |
|
|
2021
Q2 | $1.61M | Hold |
12,193
| – | – | 0.19% | 124 |
|
|
2021
Q1 | $1.56M | Hold |
12,193
| – | – | 0.2% | 121 |
|
|
2020
Q4 | $1.45M | Hold |
12,193
| – | – | 0.2% | 122 |
|
|
2020
Q3 | $1.4M | Sell |
12,193
-392
| -3% | -$46.3K | 0.21% | 110 |
|
|
2020
Q2 | $1.43M | Hold |
12,585
| – | – | 0.23% | 103 |
|
|
2020
Q1 | $1.01M | Buy |
12,585
+1,408
| +13% | +$146K | 0.2% | 123 |
|
|
2019
Q4 | $1.19M | Hold |
11,177
| – | – | 0.22% | 119 |
|
|
2019
Q3 | $1.2M | Hold |
11,177
| – | – | 0.24% | 116 |
|
|
2019
Q2 | $1.14M | Hold |
11,177
| – | – | 0.23% | 122 |
|
|
2019
Q1 | $1M | Buy |
11,177
+8,661
| +344% | +$751K | 0.21% | 121 |
|
|
2018
Q4 | $210K | Buy |
+2,516
| New | +$236K | 0.06% | 218 |
|
Other funds holding DGX
EIG
Kintegral Advisory's DGX Position: Q2 2026 in Review
Kintegral Advisory held its Quest Diagnostics (DGX) position steady in Q2 2026 at 11,984 shares worth $2.54M. The position accounts for 0.21% of the portfolio, ranked #112.
Kintegral Advisory first reported a position in DGX in Q4 2018 and has held it in 31 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Kintegral Advisory held 11,984 shares of Quest Diagnostics worth $2.54M as of Q2 2026.
- Kintegral Advisory left its Quest Diagnostics share count unchanged in Q2 2026.
- Quest Diagnostics made up 0.21% of Kintegral Advisory's portfolio in Q2 2026, its #112 holding.
- Kintegral Advisory first reported a position in Quest Diagnostics in Q4 2018 and has held it in 31 quarters since.
- 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Kintegral Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.